3-Methyl-3-buten-2-ol, (R)-

Details

Top
Internal ID 216bcd57-b283-4421-9439-12d07c083d55
Taxonomy Organic oxygen compounds > Organooxygen compounds > Alcohols and polyols > Secondary alcohols
IUPAC Name (2R)-3-methylbut-3-en-2-ol
SMILES (Canonical) CC(C(=C)C)O
SMILES (Isomeric) C[C@H](C(=C)C)O
InChI InChI=1S/C5H10O/c1-4(2)5(3)6/h5-6H,1H2,2-3H3/t5-/m1/s1
InChI Key JEYLKNVLTAPJAF-RXMQYKEDSA-N
Popularity 4 references in papers

Physical and Chemical Properties

Top
Molecular Formula C5H10O
Molecular Weight 86.13 g/mol
Exact Mass 86.073164938 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 1.20
Atomic LogP (AlogP) 0.94
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
J9GDF6FU9O
105228-58-8
(2R)-3-Methyl-3-buten-2-ol
3-Methyl-3-buten-2-ol, (+)-
3-Buten-2-ol, 3-methyl-, (2R)-
UNII-J9GDF6FU9O
(R)-3-methyl-3-buten-2-ol
(R)-3-Methyl-3-butene-2-ol
(r)-(+)-3-methyl-3-buten-2-ol
(2R)-3-METHYLBUT-3-EN-2-OL
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 3-Methyl-3-buten-2-ol, (R)-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9885 98.85%
Caco-2 - 0.6809 68.09%
Blood Brain Barrier + 0.8500 85.00%
Human oral bioavailability - 0.5286 52.86%
Subcellular localzation Mitochondria 0.3936 39.36%
OATP2B1 inhibitior - 0.8688 86.88%
OATP1B1 inhibitior + 0.9600 96.00%
OATP1B3 inhibitior + 0.9667 96.67%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9420 94.20%
P-glycoprotein inhibitior - 0.9833 98.33%
P-glycoprotein substrate - 0.9822 98.22%
CYP3A4 substrate - 0.7852 78.52%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7392 73.92%
CYP3A4 inhibition - 0.7896 78.96%
CYP2C9 inhibition - 0.9228 92.28%
CYP2C19 inhibition - 0.6463 64.63%
CYP2D6 inhibition - 0.9441 94.41%
CYP1A2 inhibition - 0.8310 83.10%
CYP2C8 inhibition - 0.9973 99.73%
CYP inhibitory promiscuity - 0.8032 80.32%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) + 0.7083 70.83%
Carcinogenicity (trinary) Non-required 0.6659 66.59%
Eye corrosion + 0.9161 91.61%
Eye irritation + 0.9680 96.80%
Skin irritation + 0.7643 76.43%
Skin corrosion + 0.6023 60.23%
Ames mutagenesis - 0.9200 92.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8114 81.14%
Micronuclear - 0.9200 92.00%
Hepatotoxicity + 0.6750 67.50%
skin sensitisation + 0.7366 73.66%
Respiratory toxicity - 0.8556 85.56%
Reproductive toxicity - 0.9667 96.67%
Mitochondrial toxicity - 0.8625 86.25%
Nephrotoxicity + 0.6091 60.91%
Acute Oral Toxicity (c) III 0.4677 46.77%
Estrogen receptor binding - 0.8913 89.13%
Androgen receptor binding - 0.9112 91.12%
Thyroid receptor binding - 0.8075 80.75%
Glucocorticoid receptor binding - 0.9083 90.83%
Aromatase binding - 0.8686 86.86%
PPAR gamma - 0.8167 81.67%
Honey bee toxicity - 0.8771 87.71%
Biodegradation + 0.7500 75.00%
Crustacea aquatic toxicity - 0.8700 87.00%
Fish aquatic toxicity - 0.3853 38.53%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 87.53% 85.14%
CHEMBL2581 P07339 Cathepsin D 86.75% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 86.54% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.47% 96.09%

Cross-Links

Top
PubChem 10678185
NPASS NPC100112
LOTUS LTS0034178
wikiData Q27281377